SCN1A (C>T) rs3812718 Polymorphism and Phenytoin-Induced Adverse Drug Reactions: Genotyping Versus Therapeutic Drug Monitoring in a Prospective Cohort.

Kumar B, Natarajan A, Nair PP

Open source

DOI
10.1097/ftd.0000000000001550
Published
2026 Nov 6
Container
Therapeutic drug monitoring
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/ftd.0000000000001550,
  title = {SCN1A (C>T) rs3812718 Polymorphism and Phenytoin-Induced Adverse Drug Reactions: Genotyping Versus Therapeutic Drug Monitoring in a Prospective Cohort.},
  author = {Kumar B and Natarajan A and Nair PP},
  year = {2026},
  journal = {Therapeutic drug monitoring},
  doi = {10.1097/ftd.0000000000001550},
  url = {https://doi.org/10.1097/ftd.0000000000001550}
}

RIS

TY  - JOUR
TI  - SCN1A (C>T) rs3812718 Polymorphism and Phenytoin-Induced Adverse Drug Reactions: Genotyping Versus Therapeutic Drug Monitoring in a Prospective Cohort.
AU  - Kumar B
AU  - Natarajan A
AU  - Nair PP
PY  - 2026
JO  - Therapeutic drug monitoring
DO  - 10.1097/ftd.0000000000001550
UR  - https://doi.org/10.1097/ftd.0000000000001550
ER  - 

APA

B, K., A, N., & PP, N. (2026). SCN1A (C>T) rs3812718 Polymorphism and Phenytoin-Induced Adverse Drug Reactions: Genotyping Versus Therapeutic Drug Monitoring in a Prospective Cohort.. Therapeutic drug monitoring. https://doi.org/10.1097/ftd.0000000000001550

Source records